A treatment for ‘Retinitis Pigmentosa’ could be in the offing
In their new study, researchers, who hailed from the Department of Biotechnology’s New Delhi-based National Institute of Immunology (DBT-NII) and Dr Rajendra Prasad Centre for Ophthalmic Sciences at All India Institute of Medical Sciences, assessed the potential of monocytes obtained from peripheral blood and have found that they do fit the bill